Market Overview

Vertex Pharmaceuticals' Recuperation Will Continue, Vetr Crowd Says


Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) have lost 28.5 percent of their value since the beginning of the year. However, the past month saw the stock gain 9.4 percent. It seems like the Vetr crowd believes the rally will continue, as suggested by its average price target of $94.50, which implies an upside potential of 6.1 percent from current valuations.

Related Link: Here's How Crowdsourced Ratings Can Beat The Market

Seeking to better reflect this upside potential, the Vetr community decided upgrade its rating on shares of Vertex on Thursday, from 3.0 Stars (Hold) to 3.5 Stars (Buy) - out of a possible 5.0 Stars rating.

Finally, it should be noted that, in accordance with the new rating, 72 percent of the crowd’s ratings are bullish.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Latest Ratings for VRTX

Nov 2019ReiteratesBuy
Nov 2019MaintainsOverweight
Nov 2019Initiates Coverage OnBuy

View More Analyst Ratings for VRTX
View the Latest Analyst Ratings

Posted-In: VetrUpgrades Price Target Crowdsourcing Analyst Ratings General


Related Articles (VRTX)

View Comments and Join the Discussion!

Latest Ratings

VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Popeyes Louisiana Kitchen Now Offers 12.75% Upside, Vetr Crowd Says

What Deutsche Bank Is Looking For In Red Hat's Earnings